Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (301-310 of 343) with videos related to

Pageof 35
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
4-1BB Agonist Focuses CD8<sup>+</sup> Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic CancerDonastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 2, 2021
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinomaRobert R McMillan, Milind Javle, Sudha Kodali, et al.
The Oncologist|January 30, 2023
Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic AnalysisGrace N Dodoo, Brian De, Sunyoung S Lee, et al.
The Oncologist|February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid TumorsSarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
The Lancet. Gastroenterology & Hepatology|August 6, 2021
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 studyMilind Javle, Sameek Roychowdhury, Robin Kate Kelley, et al.
The Journal of Clinical Investigation|March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and responseEugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2017
Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular CarcinomaManal M Hassan, Gehan Botrus, Reham Abdel-Wahab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2025
MAPK Pathway Mutations Emerge in Mutant-IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the Interferon ResponseJinkai Wan, Hatice Duygu Saatcioglu, Haley Ellis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinomaAwalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
Cancer|November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignanciesMinny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Pageof 35

Showing results (301-310 of 343) with videos related to

Sort By:
Pageof 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
4-1BB Agonist Focuses CD8<sup>+</sup> Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic CancerDonastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 2, 2021
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinomaRobert R McMillan, Milind Javle, Sudha Kodali, et al.
The Oncologist|January 30, 2023
Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic AnalysisGrace N Dodoo, Brian De, Sunyoung S Lee, et al.
The Oncologist|February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid TumorsSarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
The Lancet. Gastroenterology & Hepatology|August 6, 2021
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 studyMilind Javle, Sameek Roychowdhury, Robin Kate Kelley, et al.
The Journal of Clinical Investigation|March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and responseEugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2017
Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular CarcinomaManal M Hassan, Gehan Botrus, Reham Abdel-Wahab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2025
MAPK Pathway Mutations Emerge in Mutant-IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the Interferon ResponseJinkai Wan, Hatice Duygu Saatcioglu, Haley Ellis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinomaAwalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
Cancer|November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignanciesMinny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
Pageof 35